Associate Professor Thomas John is a medical oncologist specialising in Thoracic malignancies and genetics. He received his medical degree from Monash University and PhD from University of Melbourne in 2008. He underwent post-doctoral research using PDX models of NSCLC under the guidance of Prof Ming Tsao and Frances Shepherd in Toronto. He has received awards from the American Society of Clinical Oncology as well as the American Association for Cancer Research for his research into lung cancer and melanoma. He leads a laboratory group researching both lung cancer and mesothelioma with an interest in immunology, methylation and novel targets. He is funded by the National Health and Medical Research Council and the Cancer Council of Australia.
His research includes studying the immune microenvironment in lung cancer, mesothelioma and neuroendocrine tumours. In addition his laboratory group are investigating novel therapies and targets in mesothelioma. Currently his group are using mouse models to investigate new antibody drug conjugates and anti-apoptotic therapies in mesothelioma.
He has collaborations with other mesothelioma researchers across Australia, the Swiss Oncology group (SAKK), Prof Ming-Sound Tsao in Toronto, Canada and Prof Dean Fennel in the UK.
Abstracts this author is presenting: